Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. The company reported quarterly sales of $42.00 thousand which beat the analyst consensus estimate of $40.00 thousand by 5.00 percent.
- Headlines
- Entera Bio Q3 2024 GAAP EPS $(0.08) Misses $(0.06) Estimate, Sales $42.00K Beat $40.00K Estimate
Entera Bio Q3 2024 GAAP EPS $(0.08) Misses $(0.06) Estimate, Sales $42.00K Beat $40.00K Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
05:57
The Moldovan Parliament approved the National Defense Strategy, calling for an increase in defense spending.
05:54
COMEX Gold Futures rose by 0.71%, reported at 2654.10 USD/ounce. COMEX Silver Futures rose by 0.45%, reported at 30.410 USD/ounce.
05:50
Information search: Several Canadian federal ministers went to Florida, USA to meet with the team of elected President Trump.